Neural tube defects and folate pathway genes: Family-based association tests of gene-gene and gene-environment interactions

Environmental Health Perspectives

Volumn 114, Issue 10, 2006, Pages 1547-1552

  Boyles, Abee L ^a   Billups, Ashley V ^a   Deak, Kristen L ^a   Siegel, Deborah G ^a   Mehltretter, Lorraine ^a   Slifer, Susan H ^a   Bassuk, Alexander G ^b   Kessler, John A ^b   Reed, Michael C ^c   Nijhout, H Frederik ^c   George, Timothy M ^a   Enterline, David S ^a   Gilbert, John R ^a   Speer, Marcy C ^a   Aben, J ^d   Alysworth, A ^d   Bodurtha, J ^d   Brei, T ^d   Buran, C ^d   Iskandar, B ^d   Ito, J ^d   Lasarsky, N ^d   Mack, P ^d   Meeropol, E ^d   Mackey, J ^d   McLone, D ^d   Oakes, W J ^d   Powell, C ^d   Sawin, K ^d   Walker, M ^d   Worley, G ^d   more..

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c DUKE UNIVERSITY   (United States)

^d Duke University Medical Center ^*

Author keywords

Folate; Folic acid supplementation; Genetic association; Neural tube defects

Indexed keywords

5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE; 5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE REDUCTASE; BETAINE HOMOCYSTEINE METHYLTRANSFERASE; CARRIER PROTEINS AND BINDING PROTEINS; CYSTATHIONE BETA SYNTHASE; FOLATE RECEPTOR; FOLATE RECEPTOR 1; FOLATE RECEPTOR 2; FOLIC ACID; GLYCINE HYDROXYMETHYLTRANSFERASE; METHIONINE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1; OXIDOREDUCTASE; SOLUTE CARRIER FAMILY 19 MEMBER 1; SYNTHETASE; TRANSCOBALAMIN II; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLELE; ANENCEPHALUS; ARTICLE; ENVIRONMENTAL FACTOR; EUROPEAN AMERICAN; FAMILY ASSESSMENT; FEMALE; FOLATE METABOLISM; GENE IDENTIFICATION; GENE INTERACTION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MALE; MATERNAL NUTRITION; MENINGOMYELOCELE; NEURAL TUBE DEFECT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ALLELES; DIETARY SUPPLEMENTS; FOLIC ACID; HUMANS; NEURAL TUBE DEFECTS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33749428869     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.9166     Document Type: Article

References (41)

1. Abecasis GR, Cookson WO. 2000. GOLD - graphical overview of linkage disequilibrium. BioInformatics 16:182-183.
2. Afman LA, Lievers KJA, Kluijtmans LAJ, Trijbels FJM, Blom HJ. 2003, Gene-gene interaction between the cystathionine beta-synthase 31 base pair variable number of tandem repeats and the methylenetetrahydrofolate reductase 677C → T polymorphism on homocysteine levels and risk for neural tube defects. Mol Genet Metab 78:211-215.
3. Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ, Donnelly P. 2005. A haplotype map of the human genome. Nature 437:1299-1320.
4. Belousov YS, Welch RA, Sanders S, Mills A, Kulchenko A, Dempcy R, et al 2004. Single nucleotide polymorphism genotyping by two colour making curve analysis using the MGB Eclipse Probe System in challenging sequence environment. Hum Genomics 1:209-217.
5. De Marco P, Calevo MG, Moroni A, Arata L, Merello E, Finnell RH, et al. 2002. Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet 47:319-324.
6. Elwood JM, Little J, Elwood JH. 1992. Epidemiology and Control of Neural Tube Defects. Oxford, UK:Oxford University Press.
7. Essien FB, Wannberg SL. 1993. Methionine but not folinic acid or vitamin-B12 alters the frequency of neural-tube defects in Axd mutant mice. J Nutr 123:27-34.
8. Finkelstein JD, Martin JJ. 1984. Methionine metabolism in mammals. Distribution of homocysteine between competing pathways. J Biol Chem 259:9508-9513.
9. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113.
10. Gonzalez-Herrera L, Garcia-Escalante G, Castillo-Zapata I, Canto-Herrera J, Ceballos-Quintal J, Pinto-Escalante D, et al. 2002. Frequency of the thermolabile variant C677T in the MTHFR gene and lack of association with neural tube defects in the State of Yucatan, Mexico. Clin Genet 62:394-398.
11. Gueant-Rodriguez RM, Rendeli C, Namour B, Venuti L, Romano A, Anello G, et al. 2003. Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans. Neurosci Let 344:189-192.
12. International HapMap Project. 2005. A haplotype map of the human genome. Nature 437:1299-1320.
13. Kang SS. 1996. Treatment of hyperhomocyst(e)inemia: physiological basis. J Nutr 126:S1273-S1275.
14. Martin ER, Bass MP, Hauser ER, Kaplan NL. 2003. Accounting for linkage in family-based tests of association with missing parental genotypes. Am J Hum Genet 73:1016-1026.
15. Martin ER, Monks SA, Warren LL, Kaplan NL 2000. A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet 67:146-154.
16. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, et al. 1995. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345:149-151.
17. Morin I, Platt R, Weisberg I, Sabbaghian N, Wu Q, Garrow TA, et al. 2003. Common variant in betaine-homocysteine methyltransferase (BHMT) and risk for spina bifida. Am J Med Genet 119A:172-176.
18. Morrison K, Papapetrou C, Hol FA, Mariman EC, Lynch SA, Burn J, et al. 1998. Susceptibility to spina bifida; an association study of five candidate genes. Ann Hum Genet 62(pt5):379-396.
19. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131-137.
20. Nijhout HF, Read MC, Budu P, Ulrich CM. 2004. A mathematical model of the folate cycle: new insights into folate homeostasis. J Biol Chem 279:55008-55016.
21. Posey DL, Khoury MJ, Mulinare J, Adams MJ Jr, Ou CY. 1996. Is mutated MTHFR a risk factor for neural tube defects? Lancet 347:686-687.
22. Ramsbottom D, Scott JM, Molloy A, Weir DG, Kirke PN, Mills JL, et al. 1997. Are common mutations of cystathionine betasynthase involved in the aetiology of neural tube defects? Clin Genet 51:39-42
23. Razin A, Kantor B. 2005. DNA methylation in epigenetic control of gene expression. Prog Mol Subcell Biol 38:151-167.
24. Reed MC, Nijhout HF, Sparks R, Ulrich CM. 2004. A mathematical model of the methionine cycle. J Theor Biol 226:33-43.
25. Revilla JIG, Hernandez FN, Martin MTC, Salvador MT, Romero JG. 2003. C677T and A1298C MTHFR polymorphisms in the etiology of neural tube defects in Spanish population. Med Clin 120:441-445.
26. Rosenquist TH, Finnell RH. 2001. Genes, folate and homocysteine in embryonic development. Proc Nutr Soc 60:53-61.
27. Rosenquist TH, Ratashak SA, Selhub J. 1996. Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci USA 93:15227-15232.
28. Shields DC, Kirke PN, Mills JL, Ramsbottom D, Molloy AM, Burke H, et al. 1999. The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of the genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 64:1045-1055.
29. Slesinski MJ, Subar AF, Kahle LL 1996. Dietary intake of fat, fiber and other nutrients is related to the use of vitamin and mineral supplements in the United States: the 1992 National Health Interview Survey. J Nutr 126:3001-3008.
30. Speer MC, Nye J, McLone D, Worley G, Melvin EC, Viles KD, et al. 1999. Possible interaction of genotypes at cystathionine beta-synthase and methylenetetrahydrofolate reductase (MTHFR) in neural tube defects. NTD Collaborative Group. Clin Genet 56:142-144.
31. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, Finkelstein JD, Blom HJ, Thomas CMG, et al. 1994. Maternal hyperhomocysteinemia - a risk factor for neural-tube defects. Metab Clin Exp 43:1475-1480.
32. Stegmann K, Ziegler A, Ngo ETKM, Kohlschmidt N, Schröter B, Ermert A, et al. 1999, Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neural tube defects (NTD). Am J Med Genet 87:23-29.
33. Trembath D, Sherbondy AL, Vandyke DC, Shaw GM, Todoroff K, Lammer EJ, et al. 1999. Analysis of select folate pathway genes, PAX3, and human T in a midwestern neural tube defect population. Teratology 59:331-341.
34. van der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, van den Heuvel LP, et al. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071.
35. van der Put NM, Thomas CMG, Eskes TK, Trijbels FJ, Steegers-Theunissen RP, Mariman EC, et al. 1997. Altered folate and vitamin B-12 metabolism in families with spina bifida offspring. QJM 90:505-510.
36. van der Put NM, van den Heuvel LP, Steegers-Theunissen RP, Trijbels FJ, Eskes TK, Mariman EC, et al. 1996. Decreased methylene tetrahydrofolate reductase activity due to the 677C → T mutation in families with spina bifida offspring. J Mol Med 74:691-694.
37. Waterland RA, Jirtle RL. 2003. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 23:5293-5300.
38. Weir BS. 1996. Genetic Data Analysis II: Methods for Discrete Population Genetic Data. Sunderland, MA:Sinaur Associates
39. Weisberg IS, Park E, Ballman KV, Berger P, Nunn M, Suh DS, et al. 2003. Investigations of a common genetic methyltransferase (BHMT) variant in betaine-homocysteine in coronary artery disease. Atherosclerosis 167:205-214.
40. Wilson A, Platt R, Wu Q, Leclerc D, Christensen B, Yang H, et al. 1999. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B-12) increases risk for spina bifida. Mol Genet Metab 67:317-323.
41. Zhu HP, Curry S, Wen S, Wicker NJ, Shaw GM, Lammer EJ, et al. 2005. Are the betaine-homocysteine methyltransferase (BHMT and BHMT2) genes risk factors for spina bifida and orofacial clefts? Am J Med Genet 135A:274-277.